Editorial Point of View

Journal of Nuclear Cardiology

, Volume 14, Issue 5, pp 634-644

First online:

Nuclear cardiology will remain the “gatekeeper” over CT angiography

  • Rory HachamovitchAffiliated withDivision of Cardiology Email author 
  • , Marcelo F. Di CarliAffiliated withDivision of Nuclear Medicine/PET, Department of Radiology, Brigham and Women’s Hospital, Harvard Medical SchoolDivision of Cardiovascular Imaging, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access

Conclusion

Although CTA is a promising new modality, from an evidence-based point of view there is no data to support its use in a testing strategy, its accuracy is unlikely to be sufficiently similar to invasive catheterization to be considered its equivalent, and most importantly, it appears that stress perfusion data will be needed to select which patients may most benefit from revascularization and, hence, referral to the catheterization laboratory.